
("NMR", the "Company", or, together with its subsidiaries, the "Group")
Director/PDMR Shareholding
Following the transaction,
For further information please contact:
|
|
Canaccord Genuity
|
+44 20 7523 8000 |
Blytheweigh (Financial PR) |
+44 20 7138 3204 |
The Directors of NMR are responsible for the contents of this announcement.
About NMR
NMR is the leading supplier of essential management information to the
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. |
||
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
|
|
2 |
Reason for the notification |
|
a) |
Position/status |
Finance Director |
b) |
Initial notification /Amendment |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
|
|
b) |
LEI |
213800WRKB3WOUGNGN83 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument |
|
b) |
Nature of the transaction |
Acquisition of Ordinary Shares |
c) |
Price(s) and volume(s) |
9,974 Ordinary Shares at |
d) |
Aggregated information |
n/a - single transaction |
e) |
Date of the transaction |
|
f) |
Place of the transaction |
AQSE Growth Market |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the